Opinion: STAT+: China’s strict new supply chain regulations could create massive problems for Western biopharma companies
STAT [Unofficial]
May 4, 2026
China is now a peer competitor in drug innovation — and it intends to stay that way on its own terms, writes Dennis Kwok.
Discussion in the ATmosphere